Galera Therapeutics, Inc. (GRTX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.1759 |
| Open | 0.1706 |
| Bid | 0.1733 x 200 |
| Ask | 0.1792 x 200 |
| Day's range | 0.1701 - 0.1811 |
| 52-week range | 0.0850 - 3.5900 |
| Volume | |
| Avg. volume | 2,109,967 |
| Market cap | 9.682M |
| Beta (5Y monthly) | 2.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Galera Therapeutics Insiders Lose Out As Stock Sinks To US$0.17
The recent 19% drop in Galera Therapeutics, Inc.'s ( NASDAQ:GRTX ) stock could come as a blow to insiders who purchased...
- Zacks
All You Need to Know About Galera Therapeutics, Inc. (GRTX) Rating Upgrade to Buy
Galera Therapeutics, Inc. (GRTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Biotech Stock Roundup: SAGE, GRTX Plunge on Setback, REGN to Buy DBTX & More News
Regulatory updates from SAGE and Galera (GRTX) are in focus in the biotech sector.
© 2024 Yahoo. All rights reserved.